ESMO: New Therapy Boosts Survival in Triple Negative BrCA (CME/CE)

posted on Oct 10 by MedPage Today OB/Gyn in the Uncategorized category MILAN (MedPage Today) -- An experimental targeted agent significantly extended survival among women with hard-to-treat "triple negative" metastatic breast cancer, researchers reported here.